What nerve block is most beneficial for managing phantom pain in a patient with a left shoulder‑level upper extremity amputation?

Continuous Brachial Plexus Block for Shoulder-Level Upper Extremity Amputation Phantom Pain

For phantom limb pain following shoulder-level upper extremity amputation, a continuous peripheral nerve block targeting the brachial plexus (specifically an interscalene or infraclavicular approach) is the most beneficial intervention, with the strongest evidence supporting a 6-day continuous infusion of ropivacaine 0.2%.

Primary Recommendation: Continuous Peripheral Nerve Block

The highest quality and most recent evidence demonstrates that a 6-day continuous peripheral nerve block significantly reduces phantom limb pain at 4 weeks post-treatment 1. In this randomized, placebo-controlled trial, patients receiving ropivacaine infusion had mean pain scores of 3.0 versus 4.5 in placebo (difference 1.3, P=0.003), with benefits persisting for at least 1 month and improvements in physical and emotional dysfunction 1.

Technical Approach for Shoulder-Level Amputation

For your patient with shoulder-level amputation, the nerve catheter should target the brachial plexus proximally:

• Interscalene approach: Provides comprehensive coverage of the brachial plexus and has the most robust evidence for shoulder region analgesia 2
• Infraclavicular approach combined with suprascapular nerve block: May be considered as an alternative, though less studied for this specific indication 3
• Direct surgical placement: If revision surgery is planned, direct visualization allows optimal catheter positioning onto the brachial plexus 4

Infusion Protocol

Based on the strongest evidence 1 and supporting guidelines 2:

• Drug: Ropivacaine 0.2%
• Duration: 6-day continuous infusion
• Rate: 2-5 mL/hour with optional patient-controlled boluses of 5 mL 2
• Adjuvant: Add intravenous dexamethasone (dose not specified in evidence but commonly 4-8 mg) to prolong block duration 2

Why This Block Works for Phantom Pain

The mechanism addresses the core pathophysiology: disrupting reentrant neural pathways that sustain cortical reorganization 1. The 6-day duration appears critical—shorter single-shot blocks provide inadequate duration for neuroplastic changes 2.

Important Clinical Considerations

Contraindications and Cautions

• Respiratory compromise: At shoulder level, phrenic nerve involvement is less concerning than with intact limbs, but assess baseline pulmonary function
• Infection or coagulopathy: Standard contraindications apply 5
• Life expectancy considerations: This is appropriate for chronic phantom pain management, unlike neurolytic blocks which are reserved for cancer pain with limited prognosis 6

Expected Outcomes

• Pain reduction begins during infusion and persists for at least 4 weeks 1
• Median pain decrease of 3.0 points on 0-10 scale at 6 months for patients receiving only initial treatment 1
• Benefits diminish by 12 months, suggesting repeat treatments may be necessary 1
• No cases of phantom pain occurred in patients receiving peripheral nerve block alone in one study 7

Multimodal Adjuncts to Enhance Outcomes

While the continuous nerve block is your primary intervention, combine with:

Pharmacological

• Pregabalin or gabapentin: Anticonvulsants have controlled data supporting use in phantom limb pain 8, 9
• Morphine: Demonstrated efficacy for phantom pain 8
• Avoid: Tramadol and gabapentin show less effectiveness 8

Non-Pharmacological (High Expert Consensus)

• Functional prosthesis with proprioceptive feedback: Highest expert consensus after CBT, normalizes cortical reorganization 10
• Cognitive behavioral therapy (CBT): Strongest non-pharmacological evidence, addresses depression and maladaptive coping 10
• Mirror therapy: Supported for cortical reorganization, though your patient's shoulder-level amputation limits applicability 10, 8

Rehabilitation Strategy

Initiate early rehabilitation focusing on voluntary phantom limb movement if possible, as this enhances treatment response 11. Exercise therapy for non-affected areas should continue throughout treatment 11.

If Initial Block Fails

The evidence supports optional crossover or repeat treatment within 0-12 weeks 1. Consider:

1. Repeat 6-day continuous block: The trial protocol allowed self-selected crossover 1
2. Spinal cord stimulation: Reserved for refractory cases, with evidence showing efficacy even 30 years post-amputation 11
3. Pulsed radiofrequency: May provide temporary relief if somatosensory sensation returns 11

Practical Implementation

Ultrasound guidance is mandatory to reduce local anesthetic systemic toxicity risk 12. Calculate safe local anesthetic doses based on patient weight. For a 6-day infusion at 2-5 mL/hour of ropivacaine 0.2%, total dose remains well below toxic thresholds.

Catheter management: Ambulatory perineural catheters are feasible with clear patient instructions 12. Plan for catheter removal at day 6 with transition to oral medications 13.

This approach provides the strongest evidence-based strategy for your patient's phantom limb pain, with realistic expectations for meaningful pain reduction lasting at least 1 month, potentially requiring repeat treatments for sustained benefit.